Search Within

Ioannis Kalogirou Valtis

Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
  3. Editorial (2)
  4. Book Section (1)
  5. Research Letter (1)
Groups
  1. GME, Medicine (24)
  2. Graduate Medical Education (24)
  3. Hematology-Oncology Fellows (24)
  4. Adult Leukemia (15)
  5. Center for Hematologic Malignancies (15)
  6. Department of Medicine (15)

More Groups

People
  1. Jae Park (11)
  2. David Nemirovsky (7)
  3. Eytan Stein (5)
  4. Maria Palomba (5)
  5. Roni Shouval (5)
  6. Sean Devlin (5)

More People

Years
  1. 2025 (7)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (1)
Publications
  1. Blood (11)
  2. Blood Advances (4)
  3. Journal of Clinical Oncology (2)
  4. Transplantation and Cellular Therapy (2)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (2)
  4. Nature Publishing Group (2)
  5. American Medical Association (1)
  6. John Wiley & Sons (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults
    Editorial

    Valtis, Y. K.; Luskin, M. R.
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Development of ALL-Hematotox: Predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
    Journal Article

    Nair, M. S.; Silbert, S. K.; Rejeski, K.; Wilson, K. A.; Lamble, A. J.; Valtis, Y.; Yates, B.; Morales Arana, A.; Shouval, R.; Curran, K.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Outcomes after brexucabtagene autoleucel administered as a standard therapy for adults with relapsed/refractory B-cell ALL
    Journal Article

    Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O’Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR-tography: Longitudinal mapping of CAR-T toxicities across B-cell malignancies reveals biologically distinct and prognostically relevant toxicity phenotypes
    Meeting Abstract

    Rejeski, K.; Fei, T.; Luna, A.; Alhomoud, M.; Valtis, Y. K.; Nishimura, N.; Gomez-Llobell, M.; Accav, N. G.; Beyar-Katz, O.; Raj, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
    Meeting Abstract

    Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
    Blood (2024)

    Fulltext@MSK | Save